Yitian Fang, Lisa B. Westenberg, Julie J. M. Hamm, Jacqueline van de Wetering, Stephan J. L. Bakker, Ron W. F. de Bruin, Robert A. Pol, Robert C. Minnee
{"title":"Impact of Donor and Recipient Sex on Long-Term Outcomes Following Living Donor Kidney Transplantation: A Retrospective Dual-Center Study","authors":"Yitian Fang, Lisa B. Westenberg, Julie J. M. Hamm, Jacqueline van de Wetering, Stephan J. L. Bakker, Ron W. F. de Bruin, Robert A. Pol, Robert C. Minnee","doi":"10.1111/ctr.70335","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>The impact of donor and recipient sex on living donor kidney transplantation (LDKT) remains debated. This study investigates the impact of donor-recipient sex combinations on long-term transplant outcomes.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A dual-center retrospective study was conducted at Erasmus Medical Center (EMC) and University Medical Center Groningen (UMCG), including all LDKT patients between 2010 and 2020. Transplantations were categorized into male donor-male recipient (MDMR, <i>n</i> = 476), female donor-male recipient (FDMR, <i>n</i> = 765), male donor-female recipient (MDFR, <i>n</i> = 463), and female donor-female recipient pairs (FDFR, <i>n</i> = 372). The primary outcome was graft survival. Secondary outcomes included patient survival, delayed graft function (DGF), acute rejection, and graft function.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The 10-year death-censored graft survival rates were 85.5% (MDMR), 85.4% (FDMR), 82.8% (MDFR), and 81.8% (FDFR) (<i>p</i> = 0.38), while corresponding 10-year patient survival rates were 73.3%, 70.7%, 74.8%, and 73.6%, respectively (<i>p</i> = 0.28). Male recipients had a slightly higher DGF rate compared to females (6.9% vs. 5.6%, <i>p</i> = 0.29). The incidence of acute rejection ranged from 15.5% to 18.3% across all combinations (<i>p</i> = 0.76). FDFR pairs in recipients ≥ 60 years had significantly better graft survival (95.9% vs. 86.6% vs. 87.0% vs. 80.7%, <i>p</i> = 0.048). Cox regression model confirmed this protective effect of female donor kidneys in aged female recipients (adjusted HR 0.24, 95% CI: 0.06–0.91, <i>p</i> = 0.036). MDMR pairs consistently showed superior long-term graft function but this advantage did not translate into better graft survival.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Female recipients aged 60 or older benefit from improved graft survival when receiving female donor kidneys. While MDMR pairs consistently exhibited superior eGFR, this advantage did not translate into better graft survival.</p>\n </section>\n </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"39 10","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12478291/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Transplantation","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ctr.70335","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The impact of donor and recipient sex on living donor kidney transplantation (LDKT) remains debated. This study investigates the impact of donor-recipient sex combinations on long-term transplant outcomes.
Methods
A dual-center retrospective study was conducted at Erasmus Medical Center (EMC) and University Medical Center Groningen (UMCG), including all LDKT patients between 2010 and 2020. Transplantations were categorized into male donor-male recipient (MDMR, n = 476), female donor-male recipient (FDMR, n = 765), male donor-female recipient (MDFR, n = 463), and female donor-female recipient pairs (FDFR, n = 372). The primary outcome was graft survival. Secondary outcomes included patient survival, delayed graft function (DGF), acute rejection, and graft function.
Results
The 10-year death-censored graft survival rates were 85.5% (MDMR), 85.4% (FDMR), 82.8% (MDFR), and 81.8% (FDFR) (p = 0.38), while corresponding 10-year patient survival rates were 73.3%, 70.7%, 74.8%, and 73.6%, respectively (p = 0.28). Male recipients had a slightly higher DGF rate compared to females (6.9% vs. 5.6%, p = 0.29). The incidence of acute rejection ranged from 15.5% to 18.3% across all combinations (p = 0.76). FDFR pairs in recipients ≥ 60 years had significantly better graft survival (95.9% vs. 86.6% vs. 87.0% vs. 80.7%, p = 0.048). Cox regression model confirmed this protective effect of female donor kidneys in aged female recipients (adjusted HR 0.24, 95% CI: 0.06–0.91, p = 0.036). MDMR pairs consistently showed superior long-term graft function but this advantage did not translate into better graft survival.
Conclusions
Female recipients aged 60 or older benefit from improved graft survival when receiving female donor kidneys. While MDMR pairs consistently exhibited superior eGFR, this advantage did not translate into better graft survival.
期刊介绍:
Clinical Transplantation: The Journal of Clinical and Translational Research aims to serve as a channel of rapid communication for all those involved in the care of patients who require, or have had, organ or tissue transplants, including: kidney, intestine, liver, pancreas, islets, heart, heart valves, lung, bone marrow, cornea, skin, bone, and cartilage, viable or stored.
Published monthly, Clinical Transplantation’s scope is focused on the complete spectrum of present transplant therapies, as well as also those that are experimental or may become possible in future. Topics include:
Immunology and immunosuppression;
Patient preparation;
Social, ethical, and psychological issues;
Complications, short- and long-term results;
Artificial organs;
Donation and preservation of organ and tissue;
Translational studies;
Advances in tissue typing;
Updates on transplant pathology;.
Clinical and translational studies are particularly welcome, as well as focused reviews. Full-length papers and short communications are invited. Clinical reviews are encouraged, as well as seminal papers in basic science which might lead to immediate clinical application. Prominence is regularly given to the results of cooperative surveys conducted by the organ and tissue transplant registries.
Clinical Transplantation: The Journal of Clinical and Translational Research is essential reading for clinicians and researchers in the diverse field of transplantation: surgeons; clinical immunologists; cryobiologists; hematologists; gastroenterologists; hepatologists; pulmonologists; nephrologists; cardiologists; and endocrinologists. It will also be of interest to sociologists, psychologists, research workers, and to all health professionals whose combined efforts will improve the prognosis of transplant recipients.